Advertisement

Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

Edward A. Stadtmauer, Thomas H. Faitg, Daniel E. Lowther, Ashraf Z. Badros, Karen Chagin, Karen Dengel, Malini Iyengar, Luca Melchiori, Jean-Marc Navenot, Elliot Norry, Trupti Trivedi, Ruoxi Wang, Gwendolyn K. Binder, Rafael Amado and Aaron P. Rapoport

Article Information

Citation 
vol. 3 no. 13 2022-2034
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted March 24, 2019
  • Accepted May 14, 2019
  • Published online July 9, 2019.


Contributors 
  • Edward A. Stadtmauer, 1Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
  • Thomas H. Faitg, 2Adaptimmune, Philadelphia, PA;
  • Daniel E. Lowther, 3Adaptimmune, Abingdon, Oxfordshire, United Kingdom;
  • Ashraf Z. Badros, 4Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD; and
  • Karen Chagin, 2Adaptimmune, Philadelphia, PA;
  • Karen Dengel, 5Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Malini Iyengar, 2Adaptimmune, Philadelphia, PA;
  • Luca Melchiori, 3Adaptimmune, Abingdon, Oxfordshire, United Kingdom;
  • Jean-Marc Navenot, 2Adaptimmune, Philadelphia, PA;
  • Elliot Norry, 2Adaptimmune, Philadelphia, PA;
  • Trupti Trivedi, 2Adaptimmune, Philadelphia, PA;
  • Ruoxi Wang, 3Adaptimmune, Abingdon, Oxfordshire, United Kingdom;
  • Gwendolyn K. Binder, 2Adaptimmune, Philadelphia, PA;
  • Rafael Amado, 2Adaptimmune, Philadelphia, PA;
  • Aaron P. Rapoport, 4Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD; and

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output